Related references
Note: Only part of the references are listed.The diversity and breadth of cancer cell fatty acid metabolism
Shilpa R. Nagarajan et al.
CANCER & METABOLISM (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Overcoming enzalutamide resistance in metastatic prostate cancer by targeting sphingosine kinase
Hui-Ming Lin et al.
EBIOMEDICINE (2021)
Relationship between Circulating Lipids and Cytokines in Metastatic Castration-Resistant Prostate Cancer
Hui-Ming Lin et al.
CANCERS (2021)
Aberrations in circulating ceramide levels are associated with poor clinical outcomes across localised and metastatic prostate cancer
Hui-Ming Lin et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2021)
RB/E2F1 as a Master Regulator of Cancer Cell Metabolism in Advanced Disease
Amy C. Mandigo et al.
CANCER DISCOVERY (2021)
Plasma Cell-Free DNA Profiling of PTEN-PI3K-AKT Pathway Aberrations in Metastatic Castration-Resistant Prostate Cancer
Edmond M. Kwan et al.
JCO PRECISION ONCOLOGY (2021)
Development and variation of a ceramide- and phospholipid-based cardiovascular risk estimation score for coronary artery disease patients
Mika Hilvo et al.
EUROPEAN HEART JOURNAL (2020)
Defining a metabolic landscape of tumours: genome meets metabolism
Chandan Seth Nanda et al.
BRITISH JOURNAL OF CANCER (2020)
Combination of statin/vitamin D and metastatic castration-resistant prostate cancer (CRPC): a post hoc analysis of two randomized clinical trials
A. Carretero-Gonzalez et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2020)
Combined Cell-free DNA and RNA Profiling of the Androgen Receptor: Clinical Utility of a Novel Multianalyte Liquid Biopsy Assay for Metastatic Prostate Cancer
Heidi Fettke et al.
EUROPEAN UROLOGY (2020)
Clinical and genomic insights into circulating tumor DNA-based alterations across the spectrum of metastatic hormone-sensitive and castrate-resistant prostate cancer
Manish Kohli et al.
EBIOMEDICINE (2020)
Caveolin-1-mediated sphingolipid oncometabolism underlies a metabolic vulnerability of prostate cancer
Jody Vykoukal et al.
NATURE COMMUNICATIONS (2020)
Neuroendocrine and Aggressive-Variant Prostate Cancer
Nicholas Spetsieris et al.
CANCERS (2020)
Development and validation of a ceramide- and phospholipid-based cardiovascular risk estimation score for coronary artery disease patients
Mika Hilvo et al.
EUROPEAN HEART JOURNAL (2020)
Mortality associated with statins in men with advanced prostate cancer treated with androgen deprivation therapy
Szu-Yuan Wu et al.
EUROPEAN JOURNAL OF CANCER (2019)
Prostate cancer incidence and mortality among men using statins and non-statin lipid-lowering medications
Maria Van Rompay et al.
EUROPEAN JOURNAL OF CANCER (2019)
Genomic correlates of clinical outcome in advanced prostate cancer
Wassim Abida et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Influence of serum total cholesterol, LDL, HDL, and triglyceride on prostate cancer recurrence after radical prostatectomy
Sheng Cheng et al.
CANCER MANAGEMENT AND RESEARCH (2019)
Towards precision oncology in advanced prostate cancer
Sheng-Yu Ku et al.
NATURE REVIEWS UROLOGY (2019)
Serum glucose, triglycerides, and cholesterol in relation to prostate cancer death in the Swedish AMORIS study
Rhonda Arthur et al.
CANCER CAUSES & CONTROL (2019)
Inhibition of de novo lipogenesis targets androgen receptor signaling in castration-resistant prostate cancer
Giorgia Zadra et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
High-Throughput Plasma Lipidomics: Detailed Mapping of the Associations with Cardiometabolic Risk Factors
Kevin Huynh et al.
CELL CHEMICAL BIOLOGY (2019)
PCSK9 inhibition alters the lipidome of plasma and lipoprotein fractions
Mika Hilvo et al.
ATHEROSCLEROSIS (2018)
Metastatic Prostate Cancer
Oliver Sartor et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Circulating Tumor DNA Genomics Correlate with Resistance to Abiraterone and Enzalutamide in Prostate Cancer
Matti Annala et al.
CANCER DISCOVERY (2018)
Inhibition of cholesterol biosynthesis overcomes enzalutamide resistance in castration-resistant prostate cancer (CRPC)
Yifan Kong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Sphingolipid metabolism in cancer signalling and therapy
Besim Ogretmen
NATURE REVIEWS CANCER (2018)
A distinct plasma lipid signature associated with poor prognosis in castration-resistant prostate cancer
Hui-Ming Lin et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
A Phase I Study of ABC294640, a First-in-Class Sphingosine Kinase-2 Inhibitor, in Patients with Advanced Solid Tumors
Carolyn D. Britten et al.
CLINICAL CANCER RESEARCH (2017)
Obesity and Cancer Mechanisms: Tumor Microenvironment and Inflammation
Neil M. Iyengar et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Association between statins and clinical outcomes among men with prostate cancer: a systematic review and meta-analysis
A. D. Raval et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2016)
Integrative Clinical Genomics of Advanced Prostate Cancer
Dan Robinson et al.
CELL (2015)
Statin action favors normalization of the plasma lipidome in the atherogenic mixed dyslipidemia of MetS: potential relevance to statin-associated dysglycemia
Peter J. Meikle et al.
JOURNAL OF LIPID RESEARCH (2015)
Improved insulin sensitivity after exercise training is linked to reduced plasma C14:0 ceramide in obesity and type 2 diabetes
Takhar Kasumov et al.
OBESITY (2015)
An Efficient Single Phase Method for the Extraction of Plasma Lipids
Zahir H. Alshehry et al.
METABOLITES (2015)
Serum Lipid Profile and Risk of Prostate Cancer Recurrence: Results from the SEARCH Database
Emma H. Allott et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2014)
Obesity and Prostate Cancer: Weighing the Evidence
Emma H. Allott et al.
EUROPEAN UROLOGY (2013)
Presence of the metabolic syndrome is associated with shorter time to castration-resistant prostate cancer
J. Flanagan et al.
ANNALS OF ONCOLOGY (2011)
Body Mass Index, Prostate Cancer-Specific Mortality, and Biochemical Recurrence: a Systematic Review and Meta-analysis
Yin Cao et al.
CANCER PREVENTION RESEARCH (2011)
Sphingosine 1-phosphate and cancer
Nigel J. Pyne et al.
NATURE REVIEWS CANCER (2010)
Protection from high fat diet-induced increase in ceramide in mice lacking plasminogen activator inhibitor 1
Charmi Shah et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Probabilistic quotient normalization as robust method to account for dilution of complex biological mixtures.: Application in 1H NMR metabonomics
Frank Dieterle et al.
ANALYTICAL CHEMISTRY (2006)
Share Paper
